Valuation: PuraPharm Corporation Limited

Market Cap 158M 20.14M 17.6M 16.24M 14.93M 28.29M 1.94B 28.77M 194M 76.07M 947M 75.62M 73.96M 3.26B P/E 2024
-6.13x
P/E 2025 -4.22x
Enterprise Value 473M 60.35M 52.76M 48.67M 44.74M 84.78M 5.81B 86.23M 581M 228M 2.84B 227M 222M 9.78B EV / Sales 2024
1.42x
EV / Sales 2025 1.5x
Free-Float
34.74%
Yield 2024 *
-
Yield 2025 -
1 week+1.72%
1 month-4.84%
6 months-15.71%
Current year-16.90%
1 week 0.28
Extreme 0.285
0.3
1 month 0.28
Extreme 0.28
0.32
Current year 0.28
Extreme 0.275
0.38
1 year 0.28
Extreme 0.275
0.52
3 years 0.28
Extreme 0.275
1.26
5 years 0.28
Extreme 0.275
2
10 years 0.28
Extreme 0.275
4.39
Manager TitleAgeSince
Chief Executive Officer 65 05/05/1998
Director of Finance/CFO 38 01/01/2024
Investor Relations Contact - -
Director TitleAgeSince
Chairman 65 05/05/1998
Director/Board Member 60 02/12/2011
Director/Board Member 72 12/06/2015
Date Insider Type Main position Quantity % Market Cap.
27/07/22Other

Chief Executive Officer

30,000 0.0076%
27/07/22Other 30,000 0.0076%
03/05/22Other

Chief Executive Officer

77,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.72%-34.44%-69.27% 20.14M
+2.01%+2.86%+30.80%+47.60% 18.31B
+0.38%+1.10%+23.74%+72.74% 13.32B
+5.71%+7.77%-28.21%-53.51% 11.49B
+1.06%-0.34%+2.42%+62.69% 10.79B
+0.39%-1.50%+18.56%+86.10% 9.66B
+0.52%-1.52%-5.83%-30.09% 9.18B
+0.66%+0.44%+24.78%+198.47% 7.62B
0.00%-2.17%-21.33% - 6.81B
+0.88%+0.72%+13.57%-23.13% 6.91B
Average +1.16%+0.46%+2.41%+32.40% 9.41B
Weighted average by Cap. +1.47%+0.62%+8.98%+43.63%

Financials

2024 2025
Net sales 382M 48.74M 42.62M 39.31M 36.14M 68.47M 4.69B 69.64M 469M 184M 2.29B 183M 179M 7.9B 336M 42.88M 37.49M 34.58M 31.79M 60.23M 4.13B 61.26M 413M 162M 2.02B 161M 157M 6.95B
Net income -35.44M -4.52M -3.95M -3.65M -3.35M -6.35M -435M -6.46M -43.53M -17.08M -213M -16.98M -16.61M -733M -35.22M -4.49M -3.93M -3.62M -3.33M -6.31M -432M -6.42M -43.26M -16.98M -211M -16.87M -16.5M -728M
Net Debt 327M 41.7M 36.46M 33.63M 30.91M 58.58M 4.01B 59.58M 401M 158M 1.96B 157M 153M 6.76B 315M 40.22M 35.16M 32.44M 29.82M 56.49M 3.87B 57.46M 387M 152M 1.89B 151M 148M 6.52B
Logo PuraPharm Corporation Limited
PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.
Employees
441
Date Price Change Volume
15/07/26 HK$0.2950 0.00% 401,500
14/07/26 HK$0.2950 +3.51% 214,000
13/07/26 HK$0.2850 -5.00% 257,000
10/07/26 HK$0.3000 0.00% 52,500
09/07/26 HK$0.3000 0.00% 0

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1498 Stock